The CooperCOO +4.04%85 Quick Ratio is 0.78 as of Apr. 2026, which is 20% below its 10-year median of 0.98. GuruFocus rates COO with a GF Score™ of 85/100 and a GF Value™ of $100.85 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 854 Medical Devices & Instruments companies, The Cooper ranks worse than 84.54% on this metric.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. The Cooper's quick ratio for the quarter that ended in Apr. 2026 was 0.78.
The Cooper has a quick ratio of 0.78. It indicates that the company cannot currently fully pay back its current liabilities.
The historical rank and industry rank for The Cooper's Quick Ratio or its related term are showing as below:
COO'
s Quick Ratio Range Over the Past 10 Years
Min: 0.58 Med: 0.98 Max: 1.67
Current: 0.78
During the past 13 years, The Cooper's highest Quick Ratio was 1.67. The lowest was 0.58. And the median was 0.98.
COO's Quick Ratio is ranked worse than 84.54% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: 1.865
vs COO: 0.78
The Cooper (NAS:COO) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
The Cooper Quick Ratio Related Terms
The Cooper Quick Ratio Historical Data
* Premium members only.
The historical data trend for The Cooper's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, The Cooper's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Cooper Quick Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, The Cooper's Quick Ratio distribution charts can be found below:
* The bar in red indicates where The Cooper's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
The Cooper's Quick Ratio for the fiscal year that ended in Oct. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Cooper (COO) has a Quick Ratio of 0.78 as of Apr. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on The Cooper and its competitors. This is 20% below median its historical median of 0.98. Over the past decade, The Cooper's Quick Ratio has ranged from 0.58 to 1.67. According to the industry distribution chart, The Cooper ranks #722 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 84.5%.
Is The Cooper's Quick Ratio too high?
The Cooper's current Quick Ratio of 0.78 is 20% below median its 10-year median of 0.98. Over the past 10 years, this metric has ranged from a low of 0.58 to a high of 1.67. The Medical Devices & Instruments industry median Quick Ratio is 1.87. The Cooper's value of 0.78 is 58.2% below this industry median. Based on the distribution chart, The Cooper ranks #722 out of 854 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, The Cooper has a GF Score™ of 85/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Cooper's Quick Ratio compare to ALGN and SOLV?
According to the Medical Devices & Instruments industry distribution chart, The Cooper ranks #722 out of 854 companies for Quick Ratio. This places The Cooper in the lower half of its industry. The industry median Quick Ratio is 1.87. The Cooper's value of 0.78 is 58.2% below this benchmark. Historically, The Cooper's own Quick Ratio has ranged from 0.58 to 1.67 over the past decade. While the company's 10-year median is 0.98 vs. the industry median of 1.87, The Cooper has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Devices & Instruments company?
The median Quick Ratio among Medical Devices & Instruments companies is 1.87, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. The Cooper's current Quick Ratio of 0.78 is 58.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on The Cooper and its competitors. For the Medical Devices & Instruments industry, the median Quick Ratio is 1.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Cooper's current Quick Ratio is 0.78, which is 20% below median its own 10-year median of 0.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Cooper stock overvalued right now?
Based on GuruFocus' analysis, The Cooper (COO) is currently considered Significantly Undervalued. The stock's GF Value™ is $100.85, compared to a current price of $68.83 — trading 31.8% below its estimated fair value. The current Quick Ratio is 0.78, which is 20% below median its 10-year median of 0.98 and 58.2% below the Medical Devices & Instruments industry median of 1.87. The Cooper's overall GF Score™ is 85/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For The Cooper (COO), the current Quick Ratio is 0.78 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is The Cooper (COO) Overvalued in 2026?
Based on GuruFocus' analysis, The Cooper stock appears to be undervalued.
The current stock price of $68.83 is trading 31.8% below its estimated GF Value™ of $100.85.
GuruFocus considers The Cooper to be Significantly Undervalued.
Key valuation signals for COO:
Quick Ratio: 0.78 (20% below median its 10-year median of 0.98)
GF Value™: $100.85 vs. price of $68.83 (31.8% below fair value)
Industry Position: 58.2% below the Medical Devices & Instruments median (#722 of 854)
No single metric tells the full story. See the COO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
85GF Score
Get the complete analysis for COO
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
COO has been successfully added to your 
